XML 32 R65.htm IDEA: XBRL DOCUMENT
v3.19.3

Earnings per share (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2019
Text block [abstract] |
Summary of earnings per share |
|  | 2019 A$’000 |  |  | 2018 A$’000 |  |  | 2017 A$’000 |
Loss after income tax attributable to the owners of Kazia Therapeutics Limited |  |  | (10,270 | ) |  |  | (6,039 | ) |  |  | (10,670 | )
Loss after income tax attributable to the owners of Kazia Therapeutics Limited |  |  | (10,270 | ) |  |  | (6,039 | ) |  |  | (10,670 | )
|  | Number |  |  | Number |  |  | Number |
Weighted average number of ordinary shares used in calculating basic earnings per share |  |  | 57,503,555 |  |  |  | 48,376,525 |  |  |  | 467,833,849 |
Weighted average number of ordinary shares used in calculating Diluted earnings per share |  |  | 57,503,555 |  |  |  | 48,376,525 |  |  |  | 467,833,849 |
|  | Cents |  |  | Cents |  |  | Cents |
Basic earnings per share |  |  | (17.86 | ) |  |  | (12.48 | ) |  |  | (2.28 | )
Diluted earnings per share |  |  | (17.86 | ) |  |  | (12.48 | ) |  |  | (2.28 | )

X
- Definition The disclosure of earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 33 -IssueDate 2018-01-01 -Paragraph 66 -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=33&date=2018-03-01&anchor=para_66&doctype=Standard -URIDate 2018-03-16 + Details
Name: | ifrs-full_EarningsPerShareExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Text block [abstract] + References No definition available. + Details
Name: | kzia_TextBlockAbstract
Namespace Prefix: | kzia_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration